Literature DB >> 616864

Once daily sotalol in the treatment of hypertension.

H L Shaw.   

Abstract

In a small group of hypertensive patients studied at home, once daily early morning sotalol therapy effectively decreased lying, standing, and post-exercise blood pressure and pulse rate. A dose-response relationship was seen. Adverse effects were mild and transient. The once daily regimen is easy to administer and appears to give precision in blood pressure reduction. Providing there is no subsequent escape from control, once daily beta-blocking therapy should aid long-term hypertension treatment in general practice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 616864      PMCID: PMC2158659     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  12 in total

1.  Diseases of the cardiovascular system. Hypertension--I.

Authors:  J C Petrie
Journal:  Br Med J       Date:  1976-07-31

2.  Untoward effects associated with practolol administration: oculomucocutaneous syndrome.

Authors:  P Wright
Journal:  Br Med J       Date:  1975-03-15

3.  Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

Authors:  P M Lish; J H Weikel; K W Dungan
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

4.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

5.  Drug therapy: patient compliance.

Authors:  B Blackwell
Journal:  N Engl J Med       Date:  1973-08-02       Impact factor: 91.245

6.  To be taken as directed.

Authors:  M S Gatley
Journal:  J R Coll Gen Pract       Date:  1968-07

7.  Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol).

Authors:  P Brown; H Baddeley; A E Read; J D Davies; J McGarry
Journal:  Lancet       Date:  1974-12-21       Impact factor: 79.321

8.  Drug therapy of hypertension: what we have, what we need, what we expect.

Authors:  F Gross
Journal:  Am J Cardiol       Date:  1974-10-01       Impact factor: 2.778

Review 9.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

10.  A study of once daily tenormin (atenolol) in hypertension: some implications in patient compliance.

Authors:  A M Harris; K V Wollard; J A Tweed
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

View more
  2 in total

1.  Fixed combination of sotalol and hydrochlorothiazide in the treatment of uncomplicated hypertension.

Authors:  A Jäättelä
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.

Authors:  G Berglund; R Descamps; J A Thomis
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.